CHARACTERIZATION OF A NEW PHOTOAFFINITY DERIVATIVE OF OUABAIN - LABELING OF LARGE POLYPEPTIDE AND OF A PROTEOLIPID COMPONENT OF NA,K-ATPASE

被引：257

作者：

FORBUSH, B ^{[1
]}

KAPLAN, JH ^{[1
]}

HOFFMAN, JF ^{[1
]}

机构：

[1] YALE UNIV,SCH MED,DEPT PHYSIOL,NEW HAVEN,CT 06510

来源：

关键词：

D O I：

10.1021/bi00610a037

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：3667 / 3676

页数：10

共 49 条

[41] SIGGIA S, 1963, QUANTITATIVE ORGANIC, P497
[42] OUABAIN-SPECIFIC ANTIBODIES - IMMUNOCHEMICAL PROPERTIES AND REVERSAL OF NA+, K+-ACTIVATED ADENOSINE-TRIPHOSPHATASE INHIBITION
SMITH, TW
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (06) : 1583 - &
[43] STECKHOVEN FS, 1972, BIOCHEMISTRY, V11, P1144
[44] TOBIN T, 1975, RES COMMUN CHEM PATH, V10, P605
[45] CARDIOTONIC SITE DIRECTED IRREVERSIBLE INHIBITION OF NA+ + K+-ATPASE BY 3-AZIDOACETYLSTROPHANTHIDIN, A PHOTOCHEMICAL ANALOG OF STROPHANTHIDIN
TOBIN, T
AKERA, T
BRODY, TM
TANEJA, HR
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 35 (01) : 69 - 76
[46] WALLICK ET, 1977, FED PROC, V36, P2214
[47] YODA A, 1974, MOL PHARMACOL, V10, P810
[48] YODA A, 1975, MOL PHARMACOL, V11, P653
[49] YODA A, 1977, MOL PHARMACOL, V13, P352